Boosting Indigenous Biomedical Innovation: NMC Mandates Use of ICMR's 'Patent Mitra' Platform
GS3
The National Medical Commission has directed medical institutions to adopt the ICMR's 'Medical Innovations Patent Mitra' platform to streamline patent filing and technology transfer, fostering a robust ecosystem for indigenous healthcare research.
In a significant move to strengthen India’s biomedical research ecosystem, the National Medical Commission (NMC) has issued a directive mandating medical institutions to leverage the Indian Council of Medical Research (ICMR)’s ‘Medical Innovations Patent Mitra’ platform. This initiative is designed to bridge the gap between academic research and commercial application, providing essential support for patent filing, legal guidance, and technology transfer for government-funded medical innovations.
Historically, medical research in India has often faced hurdles in transitioning from laboratory prototypes to market-ready healthcare solutions, primarily due to a lack of awareness regarding Intellectual Property Rights (IPR) and the complexities of the patenting process. The ‘Patent Mitra’ platform acts as a single-window facilitator, offering researchers and medical professionals the technical expertise required to protect their intellectual assets. By simplifying the patenting journey, the government aims to incentivize indigenous innovation, reduce reliance on imported medical technologies, and promote the ‘Atmanirbhar Bharat’ vision in the healthcare sector.
Continue reading — free with login
JeetoBharat publishes daily UPSC current affairs mapped to the Mains syllabus. Log in to read full articles.
Log in to read full articleNo credit card required. Free registered users get unlimited access.
This article was curated using AI. While we strive for accuracy, please verify critical facts from official sources.